Oncotarget · 2012 · 70 citations · 21 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingEndometrial CancerSignal Transduction In CancerWnt SignalingBeta-catenin RegulationCanonical Beta-catenin SignalingCanonical Wnt PathwayEndometrioid NeoplasmsWnt In CancerWnt Signal TransductionWnt Signaling CascadesWnt Signaling Disruption
// David W Chan 1 , Celia SL Mak 1 , Thomas HY Leung 1 , Karen KL Chan 1 and Hextan YS Ngan 1 1 Departments of Obstetrics and Gynaecology, LKS Faculty of Medicine, the University of Hong Kong, Hong Kong SAR, P.R.China Correspondence: Hextan YS Ngan, email: // Keywords : Sox7, Wnt/β-catenin, endometrial cancer, TCF/LEF-1, CyclinD1, FGF9 Received : September 20, 2012, Accepted : November 06, 2012, Published : November 07, 2012 Abstract Although the mortality rate of endometrial cancer is comparatively low in gynecologic malignancies, a rising trend of this cancer has been observed for the past decade. The understanding of the molecular mechanism will favor for the clinical management of this disease. Aberrant activation of Wnt/β-catenin signaling pathway plays a major role in the pathogenesis of endometrioid adenocarcinoma including this cancer type. In this study, we reported that Sox7, one of Sox transcriptional factors, was frequently underexpressed in endometrial cancer and importantly, it was associated with dysregulation of the Wnt/β-catenin signaling activity. Immunohistochemical and quantitative RT-PCR analyses showed that Sox7 was underexpressed and was associated with high-grade tumor ( P =0.021), increased expressions of β-catenin ( P =0.038) and its downstream targets; CyclinD1 ( P <0.001) and FGF9 ( P <0.001). In addition, using HEK293T cell model, we found that Sox7 was able to inhibit TCF/LEF-1-dependent luciferase activity induced by Wnt-1. This was further proved by that Sox7 could significantly suppress the expressions of Wnt targets; Cyclin D1 and C-myc in endometrial cells. Immuno-fluorescent microscopy revealed that Sox7 was co-localizaed with either mutant β-catenin or TCF4 protein in nucleus, while co-immunopreciptation assay demonstrated that Sox7 could physically interact with not only wild-type but also mutant β-catenin, as well as TCF4 proteins. Functionally, enforced expression of Sox7 could significantly inhibit endometrial or endometrioid ovarian cancer cells (OEA) harboring either wild-type or mutant β-catenin. These data suggest Sox7 is a negative regulator of Wnt/β-catenin signaling pathway through impeding the transcriptional machinery of β-catenin/TCF/LEF-1 transcriptional complex, and the loss of expression may be involved in the pathogenesis of endometrial cancer.
21
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
Andrei V. Krivtsov, Amit Sinha, Trista E. North et al. · Science · 2010 · 757 citations
Medicine, Cell Biology, Oncology +17
Austin Gurney, Fumiko Axelrod, Christopher J. Bond et al. · Proceedings of the National Academy of Sciences · 2012 · 625 citations · Full text
Medicine, Cancer Biology, Oncology +16
Beta-catenin mutation in carcinoma of the uterine endometrium.
Takeo Fukuchi, Masato Sakamoto, H. Tsuda et al. · PubMed · 1998 · 363 citations
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
José Palacios, Carlos Gamallo · PubMed · 1998 · 344 citations